<?xml version="1.0" encoding="UTF-8"?>
<p id="Par8">For delayed heroin overdose death after a survival period of 5 h or more, studies report neurovascular disorders, hypoxic ischemic leukoencephalopathy, and region-specific atrophy with neuronal losses that can include the hippocampal formation, the cerebellar Purkinje cell layer and olivary nucleus (Protass 
 <xref ref-type="bibr" rid="CR405">1971</xref>; Ginsberg et al. 
 <xref ref-type="bibr" rid="CR178">1976</xref>; Gosztonyi et al. 
 <xref ref-type="bibr" rid="CR185">1993</xref>), as well as other areas (Buttner 
 <xref ref-type="bibr" rid="CR64">2011</xref>; Cadet et al. 
 <xref ref-type="bibr" rid="CR69">2014</xref>). Loss of neurons and synaptic connections is supported by postmortem reports of smaller mean relative volumes in various brain regions in individuals with OUD, including cortical areas (Danos et al. 
 <xref ref-type="bibr" rid="CR110">1998</xref>; Pezawas et al. 
 <xref ref-type="bibr" rid="CR398">1998</xref>), the basal ganglia (Muller et al. 
 <xref ref-type="bibr" rid="CR348">2015</xref>, 
 <xref ref-type="bibr" rid="CR350">2019</xref>), prefrontal cortex (Cadet et al. 
 <xref ref-type="bibr" rid="CR69">2014</xref>), and hypothalamus (Muller et al. 
 <xref ref-type="bibr" rid="CR349">2018</xref>). Interestingly, leukoencephalopathy, atrophy (Cadet et al. 
 <xref ref-type="bibr" rid="CR69">2014</xref>), and increased hyperphosphorylated tau-containing neurofibrillary tangles are reported with chronic opiate abuse compared to age-matched controls (Ramage et al. 
 <xref ref-type="bibr" rid="CR417">2005</xref>; Anthony et al. 
 <xref ref-type="bibr" rid="CR13">2010</xref>; Kovacs et al. 
 <xref ref-type="bibr" rid="CR252">2015</xref>). Glycogen synthase kinase 3 α or β (GSK-3α/β; the pan antibody used in this study does not discern α from β isoforms) and/or cyclin-dependent kinase-5 (Cdk-5) are increased in the frontal and temporal cortices, the locus coeruleus, and the hippocampus, respectively, and correlate with microgliosis (Anthony et al. 
 <xref ref-type="bibr" rid="CR13">2010</xref>). Further, more prolonged use increases the risk of accelerated age-related and even Alzheimer’s-like pathological changes (Ramage et al. 
 <xref ref-type="bibr" rid="CR417">2005</xref>; Anthony et al. 
 <xref ref-type="bibr" rid="CR13">2010</xref>; Kovacs et al. 
 <xref ref-type="bibr" rid="CR252">2015</xref>) and cognitive impairment (Gruber et al. 
 <xref ref-type="bibr" rid="CR191">2007</xref>).
</p>
